Oliver Floßmann

8.5k citations

52 papers · 4.5k indexed · 2 hit papers · h-index 26

Impact in

Genetics top 0.5%
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
Nephrology top 0.5%
- Renal Diseases and Glomerulopathies

Papers in

Genetics 30
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 30
Rheumatology 23
- Otitis Media and Relapsing Polychondritis 17
- Urticaria and Related Conditions 7

Co-authors: David Jayne Raashid Luqmani Kerstin Westman Peter Höglund Chetan Mukhtyar Alfred Mahr Michael Walsh Lorraine Harper
Journals: Annals of the Rheumatic Diseases (12 papers)Lara D. Veeken (9 papers)Nephrology Dialysis Transplantation (3 papers)Clinical and Experimental Rheumatology (1 paper)Clinical Journal of the American Society of Nephrology (1 paper)
Partner nations: United Kingdom Sweden Germany

In The Last Decade

Oliver Floßmann

51 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Long-term patient survival in ANCA-associated vasculitis 2010 · 641 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2010 Annals of the Rheumatic Diseases
2008 Annals of the Rheumatic Diseases

Peers

Countries citing papers authored by Oliver Floßmann

Since Specialization

Citations

This map shows the geographic impact of Oliver Floßmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Floßmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Floßmann more than expected).

Fields of papers citing papers by Oliver Floßmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Floßmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Floßmann. The network helps show where Oliver Floßmann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Oliver Floßmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Oliver Floßmann Line = papers co-authored together Oliver Floßmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Avacopan for ANCA-associated vasculitis with hypoxic pulmonary haemorrhage Nephrology Dialysis Transplantation ·W Gudissa, Oliver Floßmann, Rachel Jones, Jean-Baptiste Butruille, Thomas Simpson, Rona Smith, Lisa Willcocks, David Jayne	2024	13
2	Evolution of biological agents: how established drugs can become less safe BMJ ·Nicole Casadevall, Oliver Floßmann, David Hunt	2017	3
3	Thrombotic Microangiopathy in Inverted Formin 2–Mediated Renal Disease Journal of the American Society of Nephrology ·Rachel Challis, Troels Ring, Yaobo Xu, Edwin Wong, Oliver Floßmann, Ian S. Roberts, Zdenka Ševčíková, S. Krolow, 由紀子小池, Vicky Brocklebank, Igor J. Ładyko, Lisa Strain, Valerie Wilson, Katrina Wood, Kevin J. Marchbank, Mauro Santibanez‐Koref, Timothy H.J. Goodship, David Kavanagh	2016	29
4	Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis Lara D. Veeken ·Neil Basu, Andrew McClean, Lorraine Harper, E. Nicole Amft, Neeraj Dhaun, Raashid Luqmani, Mark A. Little, David Jayne, Oliver Floßmann, John McLaren, Винод Кумар, Lars P. Erwig, D M Reid, Gary J. Macfarlane, Gareth T. Jones	2014	30
5	Long-Term Follow-Up of Cyclophosphamide Compared with Azathioprine for Initial Maintenance Therapy in ANCA-Associated Vasculitis Clinical Journal of the American Society of Nephrology ·Michael Walsh, Mikkel Faurschou, Annelies E. Berden, Oliver Floßmann, Ingeborg M. Bajema, Peter Höglund, Rona Smith, Wladimir Szpirt, Kerstin Westman, Charles D. Pusey, David Jayne	2014	44
6	The characterisation and determinants of quality of life in ANCA associated vasculitis Annals of the Rheumatic Diseases ·Neil Basu, Andrew McClean, Lorraine Harper, E. Nicole Amft, Neeraj Dhaun, Raashid Luqmani, Mark A. Little, David Jayne, Oliver Floßmann, John McLaren, Винод Кумар, Lars P. Erwig, David M. Reid, Gareth T. Jones, Gary J. Macfarlane	2013	65
7	Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear Kidney International ·Michael Walsh, Alina Casian, Oliver Floßmann, Kerstin Westman, Peter Höglund, Charles D. Pusey, David Jayne	2013	169
8	Explaining fatigue in ANCA-associated vasculitis Lara D. Veeken ·Neil Basu, Andrew McClean, Lorraine Harper, E. Nicole Amft, Neeraj Dhaun, Raashid Luqmani, Mark A. Little, David Jayne, Oliver Floßmann, John McLaren, Винод Кумар, Lars P. Erwig, Donald Reid, Gary J. Macfarlane, Gareth T. Jones	2013	44
9	Determinants of Poor Quality of Life in ANCA Associated Vasculitis (AAV). Oxford University Research Archive (ORA) (University of Oxford) ·Neil Basu, Andrew McClean, Raashid Luqmani, Lorraine Harper, Oliver Floßmann, David Jayne, Mark A. Little, E. Nicole Amft, Neeraj Dhaun, Soumeya Aliouane, Veena Kumar, Lars P. Erwig, Gregory T. Jones, H. trialists, Gary J. Macfarlane	2012	1
10	Risk factors for relapse of antineutrophil cytoplasmic antibody–associated vasculitis Arthritis & Rheumatism ·Michael Walsh, Oliver Floßmann, Annelies E. Berden, Kerstin Westman, Peter Höglund, Coen A. Stegeman, David Jayne, (unknown)	2011	252
11	Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials Annals of the Rheumatic Diseases ·Caroline Heijl, Lorraine Harper, Oliver Floßmann, Isabelle Stücker, (unknown), Richard A. Watts, Peter Höglund, Kerstin Westman, Alfred Mahr	2011	111
12	Long-term damage to the ENT system in Wegener’s granulomatosis European Archives of Oto-Rhino-Laryngology ·Marcos Martinez Del Pero, Michael Walsh, Raashid Luqmani, Oliver Floßmann, Chetan Mukhtyar, Piyush Jani, Niels Rasmussen, David Jayne	2010	14
13	A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis Lara D. Veeken ·Ravi Suppiah, Chetan Mukhtyar, Oliver Floßmann, Federico Alberici, Bo Baslund, R.N. Batra, Denise Scott Brown, Julia U. Holle, Zdenka Hrušková, David Jayne, Andrew Judge, Mark A. Little, Anna Palmisano, Coen A. Stegeman, Vladimı́r Tesař, Augusto Vaglio, Kerstin Westman, Raashid Luqmani	2010	76
14	Long-term survival of ANCA-associated vasculitis Apmis ·Oliver Floßmann, Annelies E. Berden, Kirsten de Groot, Lorraine Harper, Caroline Heijl, Peter Höglund, David Jayne, Raashid Luqmani, Alfred Mahr, Chetan Mukhtyar, C D Pusey, N Rasmussen, Kerstin Westman	2009	3
15	Long-term treatment of relapsing Wegener's granulomatosis with 15-deoxyspergualin Lara D. Veeken ·Oliver Floßmann, David Jayne	2009	19
16	Cardiovascular outcomes in ANCA associated vasculitis Lund University Publications (Lund University) ·Chetan Mukhtyar, Oliver Floßmann, Denise Scott Brown, Kerstin Westman, David Jayne, Raashid Luqmani	2008	1
17	Deoxyspergualin in relapsing and refractory Wegener's granulomatosis Annals of the Rheumatic Diseases ·Oliver Floßmann, Bo Baslund, Annette Bruchfeld, J. W. Cohen Tervaert, Cindy Hall, Smith Bl, Bernhard Hellmich, Raashid Luqmani, 明阳王, Vladimı́r Tesař, David Jayne	2008	63
18	Long-term follow up of EUVAS studies Clinical and Experimental Rheumatology ·Oliver Floßmann, Lorie M. Harper, W Ramdas Singh, Raashid Luqmani, Kerstin Westman	2007	1
19	Eular recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis Annals of the Rheumatic Diseases ·Bernhard Hellmich, Oliver Floßmann, Raashid Luqmani	2006	3
20	Clinical and biological assessment in systemic necrotizing vasculitides UEA Digital Repository (University of East Anglia) ·Chetan Mukhtyar, Oliver Floßmann, Raashid Luqmani	2006	8

About Oliver Floßmann

Oliver Floßmann is a scholar working on Genetics, Rheumatology, Pulmonary and Respiratory Medicine, Nephrology and Immunology and Allergy, having authored 52 papers that have together received 4.5k indexed citations. Recurring topics across this work include Vasculitis and related conditions (46 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (30 papers), Otitis Media and Relapsing Polychondritis (17 papers), Sarcoidosis and Beryllium Toxicity Research (11 papers), Urticaria and Related Conditions (7 papers), Heparin-Induced Thrombocytopenia and Thrombosis (6 papers), Renal Diseases and Glomerulopathies (4 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Genetics (1.5k citations), Nephrology (890 citations), Pulmonary and Respiratory Medicine (4.1k citations), Rheumatology (1.8k citations) and Physiology (1.3k citations). Oliver Floßmann has collaborated with scholars based in United Kingdom, Sweden and Germany. Frequent co-authors include David Jayne, Raashid Luqmani, Kerstin Westman, Peter Höglund, Chetan Mukhtyar, Alfred Mahr, Michael Walsh, Lorraine Harper, Niels Rasmussen and Charles D. Pusey. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Nephrology Dialysis Transplantation, Clinical and Experimental Rheumatology and Clinical Journal of the American Society of Nephrology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact